Design Therapeutics, Inc. (DSGN) Capital expenditures 2020–2025
Design Therapeutics, Inc. (DSGN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$193,000FY2025 · since FY2020: $76,000 → $193,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $193,000 | -43.2% |
| FY2024 | $340,000 | +32.8% |
| FY2023 | $256,000 | -72.1% |
| FY2022 | $918,000 | -40.3% |
| FY2021 | $1.5M | +1923.7% |
| FY2020 | $76,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice